Skip to main content Accessibility help
×
Hostname: page-component-cb9f654ff-rkzlw Total loading time: 0 Render date: 2025-08-07T18:44:25.518Z Has data issue: false hasContentIssue false

Chapter 29 - Progesterone Use in Early Pregnancy

Published online by Cambridge University Press:  16 April 2025

Roy G. Farquharson
Affiliation:
Liverpool Women’s Hospital
Mary D. Stephenson
Affiliation:
University of Illinois, Chicago
Mariëtte Goddijn
Affiliation:
Amsterdam University Medical Centers
Get access

Summary

Progesterone is an endogenous hormone which is derived from cholesterol steroids. It is secreted in women principally by the corpus luteum in the ovaries during normal menstrual cycles. Progesterone exerts a number of essential effects vital for the support and maintenance of a pregnancy. The role of progesterone in threatened and recurrent miscarriage was a matter of debate for many decades, until the findings of the PROMISE and PRISM trials. Vaginal micronized progesterone may increase the live birth rate for women with a history of one or more previous miscarriages and early pregnancy bleeding, with likely no difference in adverse events. There remains an uncertainty over the effectiveness and safety of alternative progestogen treatments for threatened and recurrent miscarriage.

Information

Type
Chapter
Information
Early Pregnancy , pp. 317 - 323
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Conneely, O. M., Mulac-Jericevic, B., DeMayo, F., Lydon, J. P., O’Malley, B. W.. Reproductive functions of progesterone receptors. Recent Prog Horm Res. 2002;57:339–55.CrossRefGoogle ScholarPubMed
Gellersen, B., Fernandes, M. S., Brosens, J. J.. Non-genomic progesterone actions in female reproduction. Hum Reprod Update. 2009;15(1):119–38.Google ScholarPubMed
Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P., Conneely, O. M.. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 2000;289(5485):1751–54.CrossRefGoogle ScholarPubMed
Zakar, T., Hertelendy, F.. Progesterone withdrawal: key to parturition. Am J Obstet Gynecol. 2007 196(4):289–96.CrossRefGoogle ScholarPubMed
Zakar, T., Mesiano, S.. How does progesterone relax the uterus in pregnancy? N Eng J Med. 2011;364(10):972–73.CrossRefGoogle ScholarPubMed
Druckmann, R., Druckmann, M.-A.. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol. 2005;97(5):389–96.CrossRefGoogle ScholarPubMed
Lissauer, D., Eldershaw, S. A., Inman, C. F., Coomarasamy, A., Moss, P. A. H., Kilby, M. D.. Progesterone promotes maternal–fetal tolerance by reducing human maternal T-cell polyfunctionality and inducing a specific cytokine profile. Eur J Immunol. 2015 45(10):2858–72.CrossRefGoogle ScholarPubMed
Csapo, A. I., Pulkkinen, M. O., Kaihola, H. L.. The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus. Prostaglandins. 1973;4(3):421–49.CrossRefGoogle ScholarPubMed
Filicori, M., Butler, J. P., Crowley, W.F.. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest. 1984;73(6):1638–47.CrossRefGoogle ScholarPubMed
Jordan, J., Craig, K., Clifton, D. K., Soules, M. R.. Luteal phase deficiency: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril. 1994;62(1):5462.CrossRefGoogle Scholar
Verhaegen, J., Gallos, I. D., van Mello, N. M., Abdel-Aziz, M., Takwoingi, Y., Harb, H., et al. Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies. BMJ. 2012;345:e6077.CrossRefGoogle ScholarPubMed
Regan, L., Rai, R., Saravelos, S., Li, T. C., Royal College of Obstetricians and Gynaecologists. Recurrent miscarriage. Green-top guideline no 17. BJOG. 2023;130(12):e939.CrossRefGoogle Scholar
ESHRE Guideline Group on RPL, Bender Atik, R., Christiansen, O. B., Elson, J., Kolte, A. M., Lewis, S., et al. ESHRE guideline: recurrent pregnancy loss: an update in 2022. Hum Reprod Open. 2023;2023(1):hoad002.Google ScholarPubMed
Coomarasamy, A., Dhillon-Smith, R. K., Papadopoulou, A., Al-Memar, M., Brewin, J., Abrahams, V. M., et al. Recurrent miscarriage: evidence to accelerate action. Lancet. 2021;397(10285):1675–82.CrossRefGoogle ScholarPubMed
Coomarasamy, A., Williams, H., Truchanowicz, E., Seed, P. T., Small, R., Quenby, S., et al. (2015). A randomized trial of progesterone in women with recurrent miscarriages. N Eng J Med. 373(22):2141–48.CrossRefGoogle ScholarPubMed
Frost, J., Bradley, H., Levitas, R., Smith, L., Garcia, J.. The loss of possibility: scientisation of death and the special case of early miscarriage. Sociol Health Illn. 2007;29(7):1003–22.CrossRefGoogle ScholarPubMed
Coomarasamy, A., Devall, A. J., Cheed, V., Harb, H., Middleton, L. J., Gallos, I. D., et al. A randomized trial of progesterone in women with bleeding in early pregnancy. N Engl J Med. 2019;380(19):1815–24.CrossRefGoogle ScholarPubMed
Coomarasamy, A., Devall, A. J., Brosens, J. J., Quenby, S., Stephenson, M. D., Sierra, S., et al. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 2020;223(2):167–76.CrossRefGoogle ScholarPubMed
Coffey, F., Wright, J., Hartshorn, S., Hunt, P., Locker, T., Mirza, K., et al. STOP!: a randomized, double-blind, placebo-controlled study of the efficacy and safety of methoxyflurane for the treatment of acute pain. Emerg Med J. 2014;31(8):613–18.CrossRefGoogle ScholarPubMed
Abenhaim, H., Audibert, F., Gagnon, R., Girard, I., Kellow, Z., Klam, S., et al. Progesterone for the prevention of miscarriage and preterm birth in women with first-trimester bleeding: PREEMPT trial. J Obstet Gynaecol. 2022;44(5):599.Google Scholar
Humaidan, P., Papanikolaou, E. G., Kyrou, D., Alsbjerg, B., Polyzos, N. P., Devroey, P., et al. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reprod Biomed Online. 2012;24(2):134–41.CrossRefGoogle ScholarPubMed
Miyake, A., Aono, T., Kinugasa, T., Tanizawa, O., Kurachi, K.. Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women. J Endocrinol. 1979;80(3):353–56.CrossRefGoogle Scholar
Bourgain, C., Devroey, P., Van Waesberghe, L., Smitz, J., Van Steirteghem, A. C.. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod. 1990;5(5):537–43.CrossRefGoogle ScholarPubMed
Kolibianakis, E. M., Devroey, P.. The luteal phase after ovarian stimulation. Reprod Bimed Online. 2002;5(Suppl 1):2635.CrossRefGoogle ScholarPubMed
van der Linden, M., Buckingham, K., Farquhar, C., Kremer, J. A. M., Metwally, M.. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015;2015(7):CD009154.Google ScholarPubMed
Pritts, E. A., Atwood, A. K.. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod. 2002;17(9):2287–99.CrossRefGoogle ScholarPubMed
Kumar, A., Begum, N., Prasad, S., Aggarwal, S., Sharma, S.. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertil Steril. 2014;102(5):1357–63.e3.CrossRefGoogle Scholar
Chan, D. M. K., Cheung, K. W., Ko, J. K. Y., Yung, S. S. F., Lai, S. F., Lam, M. T., et al. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial. Hum Reprod. 2021;36(3):587–95.CrossRefGoogle ScholarPubMed
Devall, A. J., Papadopoulou, A., Podesek, M., Haas, D. M., Price, M. J., Coomarasamy, A., et al. Progestogens for preventing miscarriage: a network meta-analysis. Cochrane Database Syst Rev. 2021;4(4):CD013792.Google ScholarPubMed
NICE. Ectopic pregnancy and miscarriage: diagnosis and initial management. NICE guideline 126. 2023. www.nice.org.uk/guidance/ng126.Google Scholar
Oates-Whitehead, R. M., Haas, D. M., Carrier, J. A. K.. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2003(4):CD003511.CrossRefGoogle Scholar

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×